Caren van Roekel

283 Discussion 44. Saxena A, Meteling B, Kapoor J, Golani S, Morris DL, Bester L. Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients. Ann Surg Oncol. 2015;22(3):794-802. Epub 2014/10/18. 45. Kennedy A, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kaiser A, et al. Updated survival outcomes and analysis of long- term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases. J Gastrointest Oncol. 2017;8(4):614 -24. Epub 2017/09/12. 46. van Hazel GA, Pavlakis N, Goldstein D, Olver IN, Tapner MJ, Price D, et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol. 2009;27(25):4089-95. Epub 2009/08/05. 47. Chua TC, Bester L, Saxena A, Morris DL. Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastases. J Cancer Res Clin Oncol. 2011;137(5):865-73. Epub 2010/09/23. 48. Chauhan N, Mulcahy MF, Salem R, Benson Iii AB, Boucher E, Bukovcan J, et al. TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial. JMIR Res Protoc. 2019;8(1):e11545. Epub 2019/01/22. 49. Sabet A, Meyer C, Aouf A, Ghamari S, Pieper CC, Mayer K, et al. Early post-treatment FDG PET predicts sur vival af ter 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. Eur J Nucl Med Mol Im. 2015;42(3):370-6. Epub 2014/10/30. 50. Pfeiffer P, Yilmaz M, Möller S, Zitnjak D, Krogh M, Petersen LN, et al. TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open- label, randomised, phase 2 trial. Lancet Oncol. 2020;21(3):412-20. 51. Boas FE, Bodei L, Sofocleous CT. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes. J Nucl Med. 2017;58(Suppl 2):104S-11S. Epub 2017/09/03. 52. Turk G, Eldem G, Kilickap S, Bozkurt FM, Salanci BV, Cil BE, et al. Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience. J Gastrointest Cancer. 2019;50(2):236-43. Epub 2018/01/23. 10